Global Viral Inactivation Market Research Report 2023

Report ID: 1996142 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Viral Inactivation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Kits and Reagents
        1.2.3 Services
        1.2.4 Viral Inactivation Systems and Accessories
    1.3 Market by Application
        1.3.1 Global Viral Inactivation Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Blood and Blood Products
        1.3.3 Cellular and Gene Therapy Products
        1.3.4 Stem Cell Products
        1.3.5 Tissue and Tissue Products
        1.3.6 Vaccines and Therapeutics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Viral Inactivation Market Perspective (2017-2028)
    2.2 Viral Inactivation Growth Trends by Region
        2.2.1 Viral Inactivation Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Viral Inactivation Historic Market Size by Region (2017-2022)
        2.2.3 Viral Inactivation Forecasted Market Size by Region (2023-2028)
    2.3 Viral Inactivation Market Dynamics
        2.3.1 Viral Inactivation Industry Trends
        2.3.2 Viral Inactivation Market Drivers
        2.3.3 Viral Inactivation Market Challenges
        2.3.4 Viral Inactivation Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Viral Inactivation Players by Revenue
        3.1.1 Global Top Viral Inactivation Players by Revenue (2017-2022)
        3.1.2 Global Viral Inactivation Revenue Market Share by Players (2017-2022)
    3.2 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Viral Inactivation Revenue
    3.4 Global Viral Inactivation Market Concentration Ratio
        3.4.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2021
    3.5 Viral Inactivation Key Players Head office and Area Served
    3.6 Key Players Viral Inactivation Product Solution and Service
    3.7 Date of Enter into Viral Inactivation Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Inactivation Breakdown Data by Type
    4.1 Global Viral Inactivation Historic Market Size by Type (2017-2022)
    4.2 Global Viral Inactivation Forecasted Market Size by Type (2023-2028)
5 Viral Inactivation Breakdown Data by Application
    5.1 Global Viral Inactivation Historic Market Size by Application (2017-2022)
    5.2 Global Viral Inactivation Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Viral Inactivation Market Size (2017-2028)
    6.2 North America Viral Inactivation Market Size by Country (2017-2022)
    6.3 North America Viral Inactivation Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Viral Inactivation Market Size (2017-2028)
    7.2 Europe Viral Inactivation Market Size by Country (2017-2022)
    7.3 Europe Viral Inactivation Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Viral Inactivation Market Size (2017-2028)
    8.2 Asia-Pacific Viral Inactivation Market Size by Country (2017-2022)
    8.3 Asia-Pacific Viral Inactivation Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Viral Inactivation Market Size (2017-2028)
    9.2 Latin America Viral Inactivation Market Size by Country (2017-2022)
    9.3 Latin America Viral Inactivation Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Viral Inactivation Market Size (2017-2028)
    10.2 Middle East & Africa Viral Inactivation Market Size by Country (2017-2022)
    10.3 Middle East & Africa Viral Inactivation Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Danaher
        11.1.1 Danaher Company Detail
        11.1.2 Danaher Business Overview
        11.1.3 Danaher Viral Inactivation Introduction
        11.1.4 Danaher Revenue in Viral Inactivation Business (2017-2022)
        11.1.5 Danaher Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Viral Inactivation Introduction
        11.2.4 Merck Revenue in Viral Inactivation Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Parker Hannifin
        11.3.1 Parker Hannifin Company Detail
        11.3.2 Parker Hannifin Business Overview
        11.3.3 Parker Hannifin Viral Inactivation Introduction
        11.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2017-2022)
        11.3.5 Parker Hannifin Recent Development
    11.4 Sartorius
        11.4.1 Sartorius Company Detail
        11.4.2 Sartorius Business Overview
        11.4.3 Sartorius Viral Inactivation Introduction
        11.4.4 Sartorius Revenue in Viral Inactivation Business (2017-2022)
        11.4.5 Sartorius Recent Development
    11.5 SGS
        11.5.1 SGS Company Detail
        11.5.2 SGS Business Overview
        11.5.3 SGS Viral Inactivation Introduction
        11.5.4 SGS Revenue in Viral Inactivation Business (2017-2022)
        11.5.5 SGS Recent Development
    11.6 Charles River Laboratories International
        11.6.1 Charles River Laboratories International Company Detail
        11.6.2 Charles River Laboratories International Business Overview
        11.6.3 Charles River Laboratories International Viral Inactivation Introduction
        11.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2017-2022)
        11.6.5 Charles River Laboratories International Recent Development
    11.7 Clean Cells
        11.7.1 Clean Cells Company Detail
        11.7.2 Clean Cells Business Overview
        11.7.3 Clean Cells Viral Inactivation Introduction
        11.7.4 Clean Cells Revenue in Viral Inactivation Business (2017-2022)
        11.7.5 Clean Cells Recent Development
    11.8 Rad Source Technologies
        11.8.1 Rad Source Technologies Company Detail
        11.8.2 Rad Source Technologies Business Overview
        11.8.3 Rad Source Technologies Viral Inactivation Introduction
        11.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2017-2022)
        11.8.5 Rad Source Technologies Recent Development
    11.9 Texcell
        11.9.1 Texcell Company Detail
        11.9.2 Texcell Business Overview
        11.9.3 Texcell Viral Inactivation Introduction
        11.9.4 Texcell Revenue in Viral Inactivation Business (2017-2022)
        11.9.5 Texcell Recent Development
    11.10 Viral Inactivated Plasma Systems
        11.10.1 Viral Inactivated Plasma Systems Company Detail
        11.10.2 Viral Inactivated Plasma Systems Business Overview
        11.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
        11.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2017-2022)
        11.10.5 Viral Inactivated Plasma Systems Recent Development
    11.11 Wuxi Pharmatech (Cayman)
        11.11.1 Wuxi Pharmatech (Cayman) Company Detail
        11.11.2 Wuxi Pharmatech (Cayman) Business Overview
        11.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
        11.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2017-2022)
        11.11.5 Wuxi Pharmatech (Cayman) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Viral Inactivation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Kits and Reagents
    Table 3. Key Players of Services
    Table 4. Key Players of Viral Inactivation Systems and Accessories
    Table 5. Global Viral Inactivation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Viral Inactivation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Viral Inactivation Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Viral Inactivation Market Share by Region (2017-2022)
    Table 9. Global Viral Inactivation Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Viral Inactivation Market Share by Region (2023-2028)
    Table 11. Viral Inactivation Market Trends
    Table 12. Viral Inactivation Market Drivers
    Table 13. Viral Inactivation Market Challenges
    Table 14. Viral Inactivation Market Restraints
    Table 15. Global Viral Inactivation Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Viral Inactivation Market Share by Players (2017-2022)
    Table 17. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2021)
    Table 18. Ranking of Global Top Viral Inactivation Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Viral Inactivation Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Viral Inactivation Product Solution and Service
    Table 22. Date of Enter into Viral Inactivation Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Viral Inactivation Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Viral Inactivation Revenue Market Share by Type (2017-2022)
    Table 26. Global Viral Inactivation Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Viral Inactivation Revenue Market Share by Type (2023-2028)
    Table 28. Global Viral Inactivation Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Viral Inactivation Revenue Market Share by Application (2017-2022)
    Table 30. Global Viral Inactivation Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Viral Inactivation Revenue Market Share by Application (2023-2028)
    Table 32. North America Viral Inactivation Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Viral Inactivation Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Viral Inactivation Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Viral Inactivation Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Viral Inactivation Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Viral Inactivation Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Viral Inactivation Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Viral Inactivation Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Viral Inactivation Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Viral Inactivation Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Danaher Company Detail
    Table 43. Danaher Business Overview
    Table 44. Danaher Viral Inactivation Product
    Table 45. Danaher Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 46. Danaher Recent Development
    Table 47. Merck Company Detail
    Table 48. Merck Business Overview
    Table 49. Merck Viral Inactivation Product
    Table 50. Merck Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 51. Merck Recent Development
    Table 52. Parker Hannifin Company Detail
    Table 53. Parker Hannifin Business Overview
    Table 54. Parker Hannifin Viral Inactivation Product
    Table 55. Parker Hannifin Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 56. Parker Hannifin Recent Development
    Table 57. Sartorius Company Detail
    Table 58. Sartorius Business Overview
    Table 59. Sartorius Viral Inactivation Product
    Table 60. Sartorius Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 61. Sartorius Recent Development
    Table 62. SGS Company Detail
    Table 63. SGS Business Overview
    Table 64. SGS Viral Inactivation Product
    Table 65. SGS Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 66. SGS Recent Development
    Table 67. Charles River Laboratories International Company Detail
    Table 68. Charles River Laboratories International Business Overview
    Table 69. Charles River Laboratories International Viral Inactivation Product
    Table 70. Charles River Laboratories International Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 71. Charles River Laboratories International Recent Development
    Table 72. Clean Cells Company Detail
    Table 73. Clean Cells Business Overview
    Table 74. Clean Cells Viral Inactivation Product
    Table 75. Clean Cells Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 76. Clean Cells Recent Development
    Table 77. Rad Source Technologies Company Detail
    Table 78. Rad Source Technologies Business Overview
    Table 79. Rad Source Technologies Viral Inactivation Product
    Table 80. Rad Source Technologies Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 81. Rad Source Technologies Recent Development
    Table 82. Texcell Company Detail
    Table 83. Texcell Business Overview
    Table 84. Texcell Viral Inactivation Product
    Table 85. Texcell Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 86. Texcell Recent Development
    Table 87. Viral Inactivated Plasma Systems Company Detail
    Table 88. Viral Inactivated Plasma Systems Business Overview
    Table 89. Viral Inactivated Plasma Systems Viral Inactivation Product
    Table 90. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 91. Viral Inactivated Plasma Systems Recent Development
    Table 92. Wuxi Pharmatech (Cayman) Company Detail
    Table 93. Wuxi Pharmatech (Cayman) Business Overview
    Table 94. Wuxi Pharmatech (Cayman) Viral InactivationProduct
    Table 95. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
    Table 96. Wuxi Pharmatech (Cayman) Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Inactivation Market Share by Type: 2021 VS 2028
    Figure 2. Kits and Reagents Features
    Figure 3. Services Features
    Figure 4. Viral Inactivation Systems and Accessories Features
    Figure 5. Global Viral Inactivation Market Share by Application in 2021 & 2028
    Figure 6. Blood and Blood Products Case Studies
    Figure 7. Cellular and Gene Therapy Products Case Studies
    Figure 8. Stem Cell Products Case Studies
    Figure 9. Tissue and Tissue Products Case Studies
    Figure 10. Vaccines and Therapeutics Case Studies
    Figure 11. Viral Inactivation Report Years Considered
    Figure 12. Global Viral Inactivation Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Viral Inactivation Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Viral Inactivation Market Share by Region: 2021 VS 2028
    Figure 15. Global Viral Inactivation Market Share by Players in 2021
    Figure 16. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Viral Inactivation Revenue in 2021
    Figure 18. North America Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Viral Inactivation Market Share by Country (2017-2028)
    Figure 20. United States Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Viral Inactivation Market Share by Country (2017-2028)
    Figure 24. Germany Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Viral Inactivation Market Share by Region (2017-2028)
    Figure 32. China Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Viral Inactivation Market Share by Country (2017-2028)
    Figure 40. Mexico Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Viral Inactivation Market Share by Country (2017-2028)
    Figure 44. Turkey Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Viral Inactivation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Danaher Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 47. Merck Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 48. Parker Hannifin Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 49. Sartorius Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 50. SGS Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 51. Charles River Laboratories International Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 52. Clean Cells Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 53. Rad Source Technologies Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 54. Texcell Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 55. Viral Inactivated Plasma Systems Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 56. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Inactivation Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Frequently Asked Questions
Viral Inactivation report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Viral Inactivation report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Viral Inactivation report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Virtual Data Room

Virtual Data Room market is segmented by players, region (country), by Type and by Application. P ... Read More

Virtual Reality

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More